North South Ventures

North South Ventures (NSV) is a seed-stage VC fund dedicated to upgrading health. We identify, support, and help scale ventures that significantly improve patient health and healthcare system effectiveness. The NSV team is uniquely positioned to identify and support promising new ventures in health tech and biotech due to having expertise in medicine, science, healthcare innovation, and software engineering, along with experience in investing, entrepreneurship, and operations across startups to multi-billion-dollar enterprises. Collectively, our team has invested in over 800 companies, resulting in 16 unicorns, more than 100 FDA approvals in biotech, medical devices, and digital health/AI, and 5 IPOs on NASDAQ/NYSE. These investments have collectively raised over $10 billion in funding.